| Trial Identifier: | D5671C00008 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Parexel
|
| NCTID:: | NCT05517226 |
| Start Date: | September 2022 |
| Primary Completion Date: | February 2023 |
| Study Completion Date: | February 2023 |
| Condition: | Liver, Pancreas & Gallbladder - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| US (Spanish) |
| Country | Location |
|---|---|
| US, FL | Hialeah, FL, US, 33014 |